Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$0.37 USD
-0.01 (-3.62%)
Updated May 10, 2024 04:00 PM ET
After-Market: $0.38 +0.01 (2.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For LYRA
-
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
-
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Tops Revenue Estimates
-
Lyra Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
-
Lyra Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Misses Revenue Estimates
-
Lyra Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Lags Revenue Estimates
-
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates